DOCS insider sale: 2,000 shares via option exercise
DOCS reported a proposed sale of 2,000 common shares via a stock option exercise on 03/03/2026.
Rhea-AI Filing Summary
DOCS reported a proposed sale of 2,000 common shares via a stock option exercise on 03/03/2026. The filing lists the sale as through the issuer for cash.
It also discloses prior sales by KIRA WAMPLER, including 2,000 shares on 02/02/2026 for $74,660.00 and 2,000 shares on 01/02/2026 for $89,300.00.
Positive
- None.
Negative
- None.
Insights
Form 144 lists a 2,000-share option-based sale and two recent 2,000-share dispositions by a reporting person.
The filing documents a proposed sale of 2,000 common shares on 03/03/2026 via a stock option exercise, identified as an issuer transaction settled for cash. This follows two recorded dispositions by KIRA WAMPLER in 01/2026 and 02/2026.
Compliance considerations are routine: confirm timing against the registration requirement and ensure proceeds reporting aligns with transactional receipts; subsequent filings may disclose settlement details and exact cash flows.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the DOCS Form 144 disclose about the 03/03/2026 sale?
Who made recent sales reported in the DOCS filing?
Does the filing state who receives the sale proceeds?
Are the past transactions by KIRA WAMPLER included in the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.